QuidelOrtho [QDEL] vs Globus Medical [GMED] Detailed Stock Comparison
QuidelOrtho
NASDAQ
Loading...
Globus Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: QuidelOrtho wins in 8 metrics, Globus Medical wins in 10 metrics, with 0 ties. Globus Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | QuidelOrtho | Globus Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.92 | 23.35 | QuidelOrtho |
| Price-to-Book Ratio | 0.67 | 1.86 | QuidelOrtho |
| Debt-to-Equity Ratio | 100.33 | 2.83 | Globus Medical |
| PEG Ratio | -0.01 | 0.04 | QuidelOrtho |
| EV/EBITDA | 7.82 | 10.74 | QuidelOrtho |
| Profit Margin (TTM) | -17.01% | 13.58% | Globus Medical |
| Operating Margin (TTM) | -0.73% | 17.33% | Globus Medical |
| EBITDA Margin (TTM) | N/A | 17.33% | N/A |
| Return on Equity | -15.64% | 8.62% | Globus Medical |
| Return on Assets (TTM) | 1.36% | 5.82% | Globus Medical |
| Free Cash Flow (TTM) | $-112.10M | $405.21M | Globus Medical |
| 1-Year Return | -32.13% | -14.38% | Globus Medical |
| Price-to-Sales Ratio (TTM) | 0.69 | 3.09 | QuidelOrtho |
| Enterprise Value | $4.53B | $7.90B | Globus Medical |
| EV/Revenue Ratio | 1.65 | 3.01 | QuidelOrtho |
| Gross Profit Margin (TTM) | 44.78% | 66.62% | Globus Medical |
| Revenue per Share (TTM) | $41 | $19 | QuidelOrtho |
| Earnings per Share (Diluted) | $-6.84 | $2.54 | Globus Medical |
| Beta (Stock Volatility) | 0.27 | 1.12 | QuidelOrtho |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
QuidelOrtho vs Globus Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| QuidelOrtho | 0.54% | -10.85% | -2.14% | -9.60% | 6.34% | -38.14% |
| Globus Medical | 1.87% | 3.00% | 1.46% | 6.75% | -11.98% | -26.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| QuidelOrtho | -32.13% | -63.48% | -89.09% | 52.16% | 124.86% | 166.35% |
| Globus Medical | -14.38% | -0.58% | 9.14% | 159.87% | 347.56% | 347.56% |
News Based Sentiment: QuidelOrtho vs Globus Medical
QuidelOrtho
News based Sentiment: MIXED
October presented a complex picture for QuidelOrtho, with positive industry tailwinds offset by analyst downgrades, increased debt costs, and concerns about revenue exposure to China. While the company is focused on improving efficiency and launching new products, the overall narrative is one of significant challenges and uncertainties, making it a mixed investment story.
Globus Medical
News based Sentiment: POSITIVE
Globus Medical's acquisition of Nevro is a significant event that expands its market reach and product portfolio. While concerns about capital intensity remain, the company's strong financial position and positive analyst outlook suggest continued growth potential. The recent stock price increase indicates growing investor confidence.
Performance & Financial Health Analysis: QuidelOrtho vs Globus Medical
| Metric | QDEL | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $1.89B | $8.28B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 1,487,820 | 1,657,190 |
| 90 Day Avg. Volume | 1,319,670 | 1,334,970 |
| Last Close | $27.86 | $60.42 |
| 52 Week Range | $22.05 - $49.45 | $51.79 - $94.93 |
| % from 52W High | -43.66% | -36.35% |
| All-Time High | $306.72 (Aug 03, 2020) | $94.93 (Jan 27, 2025) |
| % from All-Time High | -90.92% | -36.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | 0.18% |
| Quarterly Earnings Growth | -0.04% | 5.39% |
| Financial Health | ||
| Profit Margin (TTM) | -0.17% | 0.14% |
| Operating Margin (TTM) | -0.01% | 0.17% |
| Return on Equity (TTM) | -0.16% | 0.09% |
| Debt to Equity (MRQ) | 100.33 | 2.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.25 | $31.81 |
| Cash per Share (MRQ) | $2.25 | $1.70 |
| Operating Cash Flow (TTM) | $200.40M | $669.16M |
| Levered Free Cash Flow (TTM) | $410.38M | $456.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: QuidelOrtho vs Globus Medical
| Metric | QDEL | GMED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.92 | 23.35 |
| Forward P/E | 10.45 | 17.34 |
| PEG Ratio | -0.01 | 0.04 |
| Price to Sales (TTM) | 0.69 | 3.09 |
| Price to Book (MRQ) | 0.67 | 1.86 |
| Market Capitalization | ||
| Market Capitalization | $1.89B | $8.28B |
| Enterprise Value | $4.53B | $7.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.65 | 3.01 |
| Enterprise to EBITDA | 7.82 | 10.74 |
| Risk & Other Metrics | ||
| Beta | 0.27 | 1.12 |
| Book Value per Share (MRQ) | $41.25 | $31.81 |
Financial Statements Comparison: QuidelOrtho vs Globus Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | QDEL | GMED |
|---|---|---|
| Revenue/Sales | $613.90M | $598.12M |
| Cost of Goods Sold | $339.00M | $195.40M |
| Gross Profit | $274.90M | $402.72M |
| Research & Development | $45.70M | $33.06M |
| Operating Income (EBIT) | $-1.80M | $98.06M |
| EBITDA | $100.00M | $160.92M |
| Pre-Tax Income | $-229.60M | $103.67M |
| Income Tax | $25.80M | $28.21M |
| Net Income (Profit) | $-255.40M | $75.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | QDEL | GMED |
|---|---|---|
| Cash & Equivalents | $127.10M | $461.27M |
| Total Current Assets | $1.26B | $1.71B |
| Total Current Liabilities | $1.05B | $384.70M |
| Long-Term Debt | $2.27B | $81.69M |
| Total Shareholders Equity | $3.00B | $4.09B |
| Retained Earnings | $123.10M | $1.04B |
| Property, Plant & Equipment | $2.35B | $1.06B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | QDEL | GMED |
|---|---|---|
| Operating Cash Flow | $41.90M | $193.84M |
| Capital Expenditures | $-56.20M | $-36.10M |
| Free Cash Flow | $9.40M | $136.20M |
| Debt Repayment | $-36.00M | $-449.99M |
| Common Stock Repurchase | N/A | $-190.45M |
Short Interest & Institutional Ownership Analysis
| Metric | QDEL | GMED |
|---|---|---|
| Shares Short | 8.15M | 6.59M |
| Short Ratio | 7.03 | 6.55 |
| Short % of Float | 0.20% | 0.07% |
| Average Daily Volume (10 Day) | 1,487,820 | 1,657,190 |
| Average Daily Volume (90 Day) | 1,319,670 | 1,334,970 |
| Shares Outstanding | 67.26M | 137.42M |
| Float Shares | 62.65M | 111.74M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.17% | 1.03% |
Dividend Analysis & Yield Comparison: QuidelOrtho vs Globus Medical
| Metric | QDEL | GMED |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |